EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations

Franck Mauvais-Jarvis, Sarah H Lindsey

Journal of Clinical Investigation · 03.09.2024 · 134 (17)

DOI: 10.1172/jci180073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.09.2024. Verfasst von Franck Mauvais-Jarvis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Service, Section of Endocrinology, Hormone Therapy Clinic, Southeast Louisiana VA Medical Center, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Testosterone, Estradiol. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testosterone (T) and 17β-estradiol (E 2 ) are produced in male and female humans and are potent metabolic regulators in both sexes. When E 2 and T production stops or decreases during aging, metabolic dysfunction develops and promotes degenerative metabolic and vascular disease. Here, we discuss the shared benefits afforded by E 2 and T for metabolic function human females and males. In females, E 2 is central to bone and vascular health, subcutaneous adipose tissue distribution, skeletal muscle insulin sensitivity, antiinflammatory immune function, and mitochondrial health. However, T also plays a role in female skeletal, vascular, and metabolic health. In males, T’s conversion to E 2 is fundamental to bone and vascular health, as well as prevention of excess visceral adiposity and the promotion of insulin sensitivity via activation of the estrogen receptors. However, T and its metabolite dihydrotestosterone also prevent excess visceral adiposity and promote skeletal muscle growth and insulin sensitivity via activation of the androgen receptor. In conclusion, T and E 2 are produced in both sexes at sex-specific concentrations and provide similar and potent metabolic benefits. Optimizing levels of both hormones may be beneficial to protect patients from cardiometabolic disease and frailty during aging, which requires further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneEstradiolHumansMaleFemaleInsulin ResistanceSex CharacteristicsAgingMuscle, SkeletalAnimals

Substanzen

TestosteroneEstradiol

Autor:innen und Institutionen

  • Medicine Service, Section of Endocrinology, Hormone Therapy Clinic, Southeast Louisiana VA Medical Center, New Orleans, Louisiana, USA.
  • Deming Department of Medicine, Section of Endocrinology and Metabolism, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Tulane Center of Excellence in Sex-Based Biology & Medicine, New Orleans, Louisiana, USA.
  • Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Förderung

  • BLRD VA
  • NIGMS NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Mauvais-Jarvis, F., & Lindsey, S. H. (2024). Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci180073

Vancouver

Mauvais-Jarvis F, Lindsey SH. Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations. Journal of Clinical Investigation. 2024;134(17). doi:10.1172/jci180073

BibTeX
@article{MauvaisJarvis2024,
  author = {Mauvais-Jarvis, Franck and Lindsey, Sarah H},
  title = {Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {17},
  doi = {10.1172/jci180073}
}
Kostenlos starten →